1. Home
  2. OCS vs CRTO Comparison

OCS vs CRTO Comparison

Compare OCS & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

SELL

Current Price

$7.96

Market Cap

732.4M

Sector

Health Care

ML Signal

SELL

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$14.39

Market Cap

751.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCS
CRTO
Founded
2003
2005
Country
Switzerland
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
732.4M
751.6M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
OCS
CRTO
Price
$7.96
$14.39
Analyst Decision
Strong Buy
Buy
Analyst Count
10
11
Target Price
★ $37.01
$20.15
AVG Volume (30 Days)
★ 316.3K
288.2K
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.95
EPS
N/A
★ 0.37
Revenue
N/A
★ $2,296,692,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$365.20
$3.30
P/E Ratio
★ N/A
$40.14
Revenue Growth
N/A
★ 27.65
52 Week Low
$7.11
$14.28
52 Week High
$34.48
$25.29

Technical Indicators

Market Signals
Indicator
OCS
CRTO
Relative Strength Index (RSI) 38.47 33.53
Support Level $7.11 N/A
Resistance Level $13.49 $19.98
Average True Range (ATR) 0.45 0.57
MACD 0.15 0.02
Stochastic Oscillator 50.87 16.05

Price Performance

Historical Comparison
OCS
CRTO

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

Share on Social Networks: